Short-chain regulatory peptides including the Khavinson bioregulator series of organ-specific oligopeptides, alongside related immunomodulatory peptides for research use.
This category centres on the Khavinson-series bioregulators: two-to-four amino acid oligopeptides developed by Professor Vladimir Khavinson, characterised by organ specificity, in which each compound is derived from a specific tissue and theorised to modulate gene expression within that same tissue type. Key Khavinson-series compounds include Epithalon (pineal), Thymalin (thymus), Pinealon (a blood-brain-barrier-penetrating tripeptide), and Cartalax (cartilage), the most studied series of tissue-specific peptide regulators in the gerontological research literature. The category also includes related immunomodulatory peptides that are not part of the Khavinson series, such as Thymosin Alpha-1, Thymulin, and HEP-1.
Mol. Wt.
432.38 g/mol
Purity
≥98%
CAS No.
N/A (modified Epitalon form)
Mol. Wt.
262.22 g/mol
Purity
≥98%
CAS No.
N/A (Khavinson bioregulator)
Mol. Wt.
3,108.31 g/mol
Purity
≥98%
CAS No.
62304-98-7
Khavinson bioregulators are ultra-short synthetic peptides studied for a proposed direct peptide-DNA interaction mechanism and geroprotector effects in preclinical models.
For in-vitro research use only. Not for human or veterinary use.
